What is ALS, also known as Lou Gehrig's disease? - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Understanding ALS, commonly referred to as Lou Gehrig's disease

  • By

  • Laura Ungar

  • February 20, 2026

Share

Objective:

To provide an overview of amyotrophic lateral sclerosis (ALS), its symptoms, diagnosis, treatment, and prognosis.

Key Findings:
  • ALS affects approximately 33,000 people in the U.S., with projections of over 36,000 by 2030.
  • The disease is more common in men and typically strikes between ages 40 and 60.
  • Patients may survive from two years to a decade after onset, with most living two to five years post-symptom development.
Interpretation:

ALS is a progressive and debilitating disease with significant impacts on mobility and respiratory function, requiring comprehensive care and support.

Limitations:
  • Diagnosis is often delayed due to the lack of specific tests.
  • Treatment options are limited and primarily focus on symptom management.
Conclusion:

ALS remains a serious health concern with no known cure, highlighting the need for ongoing research and support for affected individuals.

Original Source(s)

What is ALS, also known as Lou Gehrig's disease?

  • by Laura Ungar

  • February 20, 2026

Related Content

FDA approves first therapy for Alexander disease

The antisense oligonucleotide reduces production of the abnormal protein that accumulates in supportive cells in the brain.

Ultrasound Models Estimate Whole-Body Muscle Mass

New equations incorporating cross-sectional area improve estimation accuracy.

Misdiagnosis Common in Parkinsonian Disorders

Autopsy-confirmed findings linked diagnostic errors, co-pathology, and genetic variation to distinct pathologic patterns across more than 3,300 donors with Parkinsonian disorders.